Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	8.27% 0.982	0.907	3.027	1.215	0.545
Operating Income/Loss	2.47% -2.119	-2.068	-3.923	-6.429	-3.912
Income/Loss From Continuing Operations Before Tax	20.27% 0.617	0.513	-4.016	-7.602	0.524
Income/Loss From Continuing Operations After Tax	20.27% 0.617	0.513	-4.016	-7.602	0.524
Net Income/Loss	20.27% 0.617	0.513	-4.016	-7.602	0.524
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	76.92% -0.023	-0.013	-0.009	-0.066	-0.051
Basic Average Shares	57.65% 3.4366	8.1142	-	5.5648	0.7436
Basic Earnings Per Share	833.33% 0.56	0.06	-0.52	-1.35	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-